Ironwood Pharmaceuticals | IRWD - 应收帐款人

股票价格
4.43
每天变化
0.10 2.31%
每月一次
39.75%
每年
528.46%
Q2 预测
3.53


金融业
股票价格
USD
资产
USD 396.06M
现金及等价物
USD 140.41M
销售成本
USD 29.83M
流动资产
USD 273.84M
流动负债
USD 242.5M
债务
USD 583.99M
EBIT
USD 33.22M
EBITDA
USD 81.81M
员工
267
EPS每股收益
USD -0.01
股本和储备
USD -264.16M
销售毛利
USD 85.24M
债务利息支出
USD 8.74M
利息收入
USD 778K
贷款资金
USD 583.99M
市值
USD 677.8M
净收入
USD 3.19M
营业费用
USD 57.33M
营业利润
USD 33.22M
普通股股本
USD 160K
PE价格收益
204.24
税前利润
USD 68.02M
销售收入
USD 47.71M
销售和管理费用
USD 33.33M
贸易债权人
USD 1.61M
应收帐款人
USD 81.89M


应收帐款人 更改 日
Acadia Pharmaceuticals USD 148.23M 8.79M 2025-12
Agios Pharmaceuticals USD 10.58M 5.55M 2025-12
Akebia Therapeutics USD 47.03M 19.19M 2025-12
Almirall EUR 175.93M 17.87M 2025-12
Alnylam Pharmaceuticals USD 777.57M 187.2M 2025-12
Amarin USD 126.83M 477K 2025-12
Ardelyx USD 71.85M 4.76M 2025-12
Astellas Pharma JPY 810.23B 75.43B 2025-12
AstraZeneca USD 19.05B 1.49B 2025-12
Charles River Laboratories USD 1.43B 54.59M 2025-12
Coherus Biosciences USD 18.42M 232.08M 2025-12
Emergent BioSolutions USD 290.1M 134.2M 2023-06
Esperion Therapeutics USD 140.19M 21.21M 2025-12
Halozyme Therapeutics USD 441.27M 95.24M 2025-12
Incyte USD 1.02B 128.52M 2025-12
Ironwood Pharmaceuticals USD 81.89M 5.68M 2024-12
Karyopharm Therapeutics USD 26.18M 5.6M 2025-12
Lexicon Pharmaceuticals USD 2.38M 50K 2025-12
MacroGenics USD 13.37M 55.86M 2025-12
Moderna USD 184M 862M 2025-12
Myriad Genetics USD 115.3M 2.7M 2025-12
Pacira USD 124.07M 8.8M 2025-12
PTC Therapeutics USD 181.62M 21.45M 2025-12
Puma Biotechnology USD 28.1M 3.52M 2024-06
Sarepta Therapeutics USD 398.23M 2.49M 2025-12
Takeda JPY 757.92B 55.68B 2025-12
Ultragenyx Pharmaceutical USD 112.54M 11.92M 2025-09
Vanda Pharmaceuticals USD 47.1M 4.35M 2024-12